The Times Australia
Google AI
PR Newswire

.

Zymo Research Obtains CE IVD Mark for its Quick SARS-CoV-2 Multiplex Kit-PR Newswire APAC

Zymo Research Obtains CE IVD Mark for its Quick SARS-CoV-2 Multiplex Kit-PR Newswire APAC

Low cost, high-sensitivity diagnostic test for COVID-19 detection

IRVINE, Calif., Nov. 10, 2020 /PRNewswire/ -- Zymo Research announced today that it obtained a CE IVD mark for the Quick SARS-CoV-2 Multiplex Kit in compliance with the Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. The Quick SARS-CoV-2 Multiplex Kit[1] is a real-time reverse transcription PCR (RT-PCR) test used for the qualitative detection of nucleic acids from SARS-CoV-2 (the virus that causes COVID-19) in upper and lower respiratory specimens taken from patients whose healthcare providers suspect have contracted COVID-19.

Zymo Research obtained the CE IVD mark for its Quick SARS-CoV-2 Multiplex Kit. Zymo Research obtained the CE IVD mark for its Quick SARS-CoV-2 Multiplex Kit.

The Quick SARS-CoV-2 Multiplex Kit has a limit of detection (LoD) of 10-virus copies/reaction and up to 382 samples can be analyzed for each RT-PCR run. This high performance, combined with increased throughput, competitive pricing, and a widespread distribution network, makes this test among the best on the market.* The kit is ideal for clinical diagnostic labs that currently offer or want to offer COVID-19 testing including hospitals, universities, research centers, as well as laboratories that perform environmental surveillance for SARS-CoV-2.

The kit is easy to use in any lab equipped with RT-PCR instrumentation that is capable of detecting HEX (or VIC) and Quasar 670 (or Cy5) fluorophores. It comes in multiple formats (100-, 1,000-, or 10,000-test quantities), which make it amenable for use in small or large laboratories. With a strong international distribution network and a high production capacity, Zymo Research is capable of meeting the high-volume reagent demands of laboratories around the globe.

"With over 46 million** COVID-19 cases reported worldwide, our goal is to help stop the spread of SARS-CoV-2 by enabling increased testing," said Dr. Paolo Piatti, Senior Scientist at Zymo Research. "The CE IVD mark, along with the competitive pricing, makes this high-quality product readily accessible to laboratories and ultimately expands the availability of COVID-19 testing to many more facilities throughout the world."

For more information about Zymo Research's Quick SARS-CoV-2 Multiplex Kit and workflow, please visit their website[2] or contact them via email at covid19requests@zymoresearch.com[3].

About Zymo Research Corp.Zymo Research is a privately owned company that has been serving the scientific and diagnostics community with state-of-the-art molecular biology tools since 1994. "The Beauty of Science is to Make Things Simple" is their motto, reflected in all of their products, from epigenetics to DNA/RNA purification technologies. Historically recognized as the leader in epigenetics, Zymo Research is breaking boundaries with novel solutions for sample collection, microbiomic measurements, diagnostic devices, and NGS technologies that are high quality and simple to use. Follow Zymo Research on Facebook[4], LinkedIn[5], Twitter[6], and Instagram[7].

References* https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-reference-panel-comparative-data **https://www.statista.com/statistics/1087466/covid19-cases-recoveries-deaths-worldwide/[8][9]

Photo - https://mma.prnasia.com/media2/1330735/zymo_research_corp_quick_sars_cov_2_multiplex_kit_ce_ivd.jpg?p=medium600[10] Logo - https://mma.prnasia.com/media2/364743/Zymo_Research_Corp_Logo.jpg?p=medium600[11]

Source: Zymo Research Corp.

Read more https://www.prnasia.com/story/archive/3186131_AE86131_0

Business Times

Australia has set new expectations for AI data centres – they sho…

Yesterday, the Australian federal government released new expectations[1] for data centres and artificial intelligence ...

AI Is Already Here. The Question Is Whether Your Business Is Buil…

We sat down with Nirlep Adhikari — CTO at LoanOptions.ai and Founder of Mount Mindforce — to cut through the noise and ta...

Is Hiring a Web Developer Still Worth It?

It’s a fair question to ask in 2026. With AI tools promising to build you a website in minutes and drag-and-drop platform...

The Times Features

Compulsory super is higher than ever at 12%. But cutting it would hurt low-paid workers most

A central element of Australia’s superannuation system is the superannuation guarantee[1] (SG). ...

Grants open for port communities across the Hunter and Northern Rivers regions

Local organisations doing important work across the Hunter and Northern Rivers regions are being...

AI Is Already Here. The Question Is Whether Your Business Is Built for It

We sat down with Nirlep Adhikari — CTO at LoanOptions.ai and Founder of Mount Mindforce — to cut...

Cleared to Land — and Cleared to Die: How a Runway Failure Killed Two Pilots in Seconds

A modern passenger jet, operating under full clearance, descending onto a controlled runway at o...

Leader of The Nationals Matt Canavan - press conference

CANBERRA PARLIAMENT HOUSE PRESS CONFERENCE WITH SHADOW WATER MINISTER MICHAEL McCORMACK; MURRAY-DA...

The Power Of An Uncomfortable Love

How challenging relationships can help us grow. Never have we lived in a time where relationshi...

US country favourite Larry Fleet joins 2026 Gympie Music Muster

Tennessee singer-songwriter Larry Fleet will bring his band to the Gympie Music Muster on Friday...

56 OF YOUR FAVORITE DISNEY STARS SHINE BRIGHT IN DISNEY ON ICE PRESENTS MAGIC IN THE STARS!

The most Disney characters in one show and the on-ice debut of Raya from Raya and the Last Dragon...

How much do you really need to retire? It’s probably a lot less than $1 million

Every few months, someone in the superannuation industry declares that Australians now “need” ar...